CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

CAPRCAPRICOR THERAPEUTICS, INC.

NASDAQ · Pharmaceutical Preparations
Last close $9.47 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$550.58M
RECENT INSIDER TRADES
  • 2026-06-29 · Bergmann Anthony (CHIEF FINANCIAL OFFICER) · SELL
  • 2026-06-29 · Krasney Karen (EVP, GENERAL COUNSEL) · SELL
  • 2026-06-24 · Bergmann Anthony (CHIEF FINANCIAL OFFICER) · SELL
  • 2026-06-24 · Krasney Karen (EVP, GENERAL COUNSEL) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders183
Shares held44,308,736
Value$1.04B
Percent of shares outstanding76.21%
As of quarter end2026-06-30
RECENT NEWS
  • Capricor Therapeutics, Inc. Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy Transcript
  • Capricor Therapeutics presents HOPE-3 data on deramiocel for Duchenne muscular dystrophy
  • CAPR INVESTOR DEADLINE: Rosen Law Firm Reminds Capricor Therapeutics, Inc
  • CAPR DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc
  • CAPR: Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (CAPR) Investors to Their Right to Seek Lead Plaintiff Status Before September 29, 2026
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
CAPRICOR THERAPEUTICS, INC. (CAPR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit